Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001140361-26-006326 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-20 | 2026-02-18 | RCKT | Shah Gaurav | CEO | S - Sale | $3.34 | -5,990 | 1.05M | -0.6% | -$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | S | D | 5,990 | $3.34 | 1,046,055 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |